Critical Differences between Pneumococcal Polysaccharide Enzyme-Linked Immunosorbent Assays with and without 22F Inhibition at Low Antibody Concentrations in Pediatric Sera
Open Access
- 1 March 2006
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 13 (3) , 356-360
- https://doi.org/10.1128/cvi.13.3.356-360.2006
Abstract
A comparative study was conducted between two laboratories in order to evaluate the differences between two enzyme-linked immunosorbent assay (ELISA) techniques for the detection of pneumococcal anti-capsular polysaccharide antibodies. One laboratory used an assay including heterologous 22F polysaccharide inhibition, and the other laboratory employed a non-22F reference assay. After conjugate immunization, 30 pediatric post-primary immunization sera with antipolysaccharide concentrations ranging from 1 μg/ml. However, at antibody levels of <1 μg/ml, the distribution curve measured with the 22F inhibition ELISA shifted toward lower levels. This observation suggests that the 22F inhibition assay is more specific at low antibody concentrations, which was confirmed by heterologous polysaccharide inhibition experiments. Translation of low antibody levels suggested that the proposed threshold concentration of 0.35 μg/ml determined with the non-22F ELISA corresponded to a concentration of 0.20 μg/ml with the 22F inhibition ELISA. Pneumococcal antipolysaccharide ELISA including 22F inhibition can be recommended as a reference method.Keywords
This publication has 14 references indexed in Scilit:
- Effects of Absorption with Pneumococcal Type 22F Polysaccharide on Maternal, Cord Blood, and Infant Immunoglobulin G Antipneumococcal Polysaccharide AntibodiesClinical and Vaccine Immunology, 2005
- Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected AdultsClinical and Vaccine Immunology, 2004
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trialThe Lancet, 2003
- Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infantsVaccine, 2003
- Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent AssayClinical and Diagnostic Laboratory Immunology, 2001
- Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific?Clinical and Diagnostic Laboratory Immunology, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- The Reverse Cumulative Distribution Plot: A Graphic Method for Exploratory Analysis of Antibody DataPediatrics, 1995
- Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-SClinical and Diagnostic Laboratory Immunology, 1995